• New regulations to accompany the introduction of HRT prepayment certificates (HRT PPCs)

    The Department of Health and Social Care (DHSC) has introduced new pharmaceutical regulations, to take effect on 1 April 2023, to accompany the introduction of the HRT PPC. They are within the  National Health Service (Amendments Relating to Pre-Payment Certificates, Hormone Replacement Therapy Treatments and Medicines Shortages) Regulations 2023. The HRT PPC is a new,

    Read more
  • PSNC Regional Representative and non-CCA Multiple Elections – ballots start 9 March

    We have now collated the formal nominations submitted from all those standing for election as an Independent regional representative or a non-CCA Multiple representative on PSNC (Community Pharmacy England).  Independent Regional Representative Elections:  In four of the ten PSNC regions more than one valid nomination was received, and a ballot will be held. These regions

    Read more
  • Retrospective pricing adjustments for Venofer, Ferinject and Aptamil products

    Following representations from PSNC, the Department of Health and Social Care (DHSC) has confirmed that the following products have been granted upward retrospective pricing adjustments due to out of date product and/or pricing information held on NHS dictionary of medicines and devices (dm+d): To apply for June 2022 prescriptions: Aptamil® Anti-Reflux powder (800 gram) –

    Read more
  • MHRA Class 2 Medicines Recall: Levothyroxine 12.5mcg Tablets (Teva UK Limited)

    Drug alert number: EL(23)A/06 Date issued: 2 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Levothyroxine 12.5mcg Tablets (Teva UK Limited) – PL 00289/1971 Batch Number Expiry Date Pack Size First Distributed 214052 10 2023 28 tablets 20 July 2022 Active Pharmaceutical Ingredients: Levothyroxine Sodium

    Read more
  • PQS reminder: Declaration closes this Friday

    Community pharmacy contractors are reminded that they have until 11.59pm on Friday (3rd March 2023) to make their Pharmacy Quality Scheme (PQS) 2022/23 declaration through the MYS portal, as the window for claiming this payment will then close. Contractors must have evidence to demonstrate meeting the gateway criteria and the domains that they have claimed for by

    Read more
  • February 2023 Price Concessions Final Update

    The Department of Health and Social Care (DHSC) has today (28/02/2023) granted the following final list of price concessions for February 2023: Drug Pack size Price concession Amiloride 5mg tablets 28 £13.15 Bisoprolol 2.5mg tablets 28 £1.10 Bumetanide 1mg/5ml oral solution sugar free 150 £235.00 Calamine lotion 200 £1.51 Carvedilol 6.25mg tablets 28 £1.35 Chlorphenamine

    Read more
  • Digital Communications and Policy Support Officer job opportunity

    PSNC is looking to recruit a new Digital Communications and Policy Support Officer. This role will support both our busy communications function (we send newsletters to our c.20,000 subscribers, as well as welcoming some 8,000 people daily to our website) and our LPC and wider Contractor Support. The role will report to the Pharmacy Communications

    Read more
  • Data Security and Protection Toolkit Workshop now on-demand

     Community pharmacy contractors can now access a recording of PSNC’s recent online workshop to help with completion of the Data Security and Protection Toolkit for 2022/2023. Feedback on the webinar “Very worthwhile watching.” “Perfect. To the point, no wasted time. Answer the questions clearly and concisely.” “I think it was long enough, slides were clear

    Read more
  • Service case study: Liverpool Community Pharmacy Sexual Health Service

    The Liverpool Community Pharmacy Sexual Health Service is commissioned by Liverpool University Hospitals NHS Foundation Trust, on behalf of Liverpool City Council, to provide sexual health services to the residents of Liverpool. The pharmacy service forms part of an integrated sexual health service offer, that incorporates community contraception services, genito-urinary medicine, and sexual health promotion.

    Read more
  • February SSP updates

    Pharmacy contractors should note a number of changes that have been made to different SSPs. SSP Extensions SSP029 for Sandrena® 0.5mg and 1mg gel sachets – restriction has been extended to 31 March 2023. It was previously set to expire on 28 February 2023. SSP030 for Sandrena® 0.5mg and 1mg gel sachets – substitution has been extended to

    Read more